Australia’s TGA provisionally approves Celltrion’s Regkirona® (regdanvimab) for COVID-19

Dec 6, 2021

Australia’s TGA provisionally approved Celltrion’s Regkirona® (regdanvimab) for the treatment of adults with coronavirus who do not require supplemental oxygen and are at increased risk of progressing to severe COVID-19.

Print Page Mail Article